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Abstract 
Purpose: To assess the safety of ethanol extract of Uvaria chamae root consumption for the treatment 
of diseases in traditional medicine. 
Methods: Uvaria chamae was extracted with ethanol, and administered orally to rats at doses ranging 
from 200 to 5000 mg/kg/day for 28 days while distilled water  was administered to the  control group, the  
survived  animals (43 %),  were then euthanized, and blood collected for biochemical and 
haematological markers. Histopathological examination of the pancreas, liver and kidney sections were 
also done.  
Results: There was a significant (p < 0.05) elevation in serum AST and a significant (p < 0.05) 
reduction in LDH at 500 mg and 200 mg respectively. Serum BUN was significantly (p < 0.05) reduced, 
while chloride and potassium ions were significantly (p < 0.05) elevated at 200 and 500 mg respectively. 
However, there was a significant (p < 0.05) decrease in mean corpuscular haemoglobin (MCHC) at 200 
mg, and a significant (p < 0.05) increase in platelets at 500 mg/kg of extract. Examination of 
haematoxylin and eosin stained sections of pancreas showed well-formed islets; mild portal vascular 
congestion in liver sections; and periportal and interstitial infiltrates of lymphocytes in the liver and 
kidney sections of the surviving animals respectively.  
Conclusion: The consumption of extract at low doses may not be harmful. 
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Uvaria chamae (P. Beauv) belongs to the family 
of Annonacaea. It is a climbing large shrub or 
small tree native to the tropical rain forest of 
West and Central Africa where it grows in wet 
and coastal shrub lands [1]. It is extensively 
branched with sweet, aromatic and alternate 
leaves commonly used to cure diseases like 
piles, epistaxis, menorrhagia, hematuria and heal 
injuries [2]. It is a common ingredient for the 
preparation of Agbo in Lagos, Nigeria chiefly for 
febrile conditions in children. In folk medicine it is 
used to treat diabetes, gonorrhea and respiratory 
infections. It is also used to make pomade in 
Ghana and for severe abdominal pain and 
dysentery. In Sierrra Leone, it is used to treat 
yellow fever, jaundice and cough, while in 
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Senegal, it is used for treating renal and infantile 
rickets [2].  
 
Some U. chamae users commonly cut the root 
into small pieces and soak in a bottle containing 
local gin (alcohol) and drink a small glass full 
(about 30 ml) daily. Previous studies have 
reported antifungal, bacteriostatic and 
antimalaria properties of Uvaria chamae 
preparations [4-6]. The chemical composition of 
U. chamae root include C-benzylated 
monoterpenes, dihydrochalcones and aromatic 
oils [7], flavanones and C-benzylated flavanones 
[8].  
 
Although, the acute and subchronic toxicity 
studies of aqueous extract of Uvaria chamae had 
earlier been reported [9], herbal practitioners also 
use ethanol extract to treat various diseases, 
hence this study was designed to ascertain the 




Plant material and extraction  
 
Fresh root pieces of wild Uvaria chamae grown 
in Igwo, Oyo state of Nigeria were purchased 
from the herbal market, at Oyingbo, in Lagos, 
Nigeria. Root pieces of the plant were identified 
and authenticated by Dr. Henry Akinnibosun, a 
taxonomist, at the Department of Plant Biology 
and Biotechnology, Faculty of Life Sciences, 
University of Benin, Benin City, Nigeria with a 
voucher number UBH 266, and deposited at the 
Herbarium [9]. The root sample was pulverized 
and then soaked in absolute ethanol for 72 hours 
with intermittent stirring to allow for percolation 
and maceration [10]. It was then rotary 
evaporated, and freeze dried to obtain 139 g 
from 3312 g of the plant root and stored in the 




Sprague Dawley rats were purchased from the 
Department of Anatomy, University of Benin, 
Benin City, Nigeria. The rats [average body 
weight 190.49 ± 2.86 g] were housed in clean 
cages under standard laboratory conditions of 
temperature, humidity and light at the animal 
house, Department of Biochemistry, Faculty of 
Life Sciences, University of Benin, Benin City 
and had free access to standard laboratory diet 
and distilled water for a period of two weeks for 
acclimatization.  Ethical approval for the study 
was obtained from the Ethical Board of the 
Department of Biochemistry, University of Benin, 
Benin City. 
 
Subchronic oral toxicity 
 
Forty-two (42) Sprague Dawley rats were used 
for this study and grouped per sex and weight 
(average body weight 190.49 ± 2.86 g) into 
seven groups as follows: group one (Normal rats 
+ distilled water), group two (Normal rats + 200 
mg/kg of extract), group three (Normal rats + 500 
mg/kg of extract), group four (Normal rats + 1000 
mg/kg of extract), group 5 (Normal rats + 2000 
mg/kg body weight of extract), group six  (Normal 
rats + 3000 mg/kg body weight of extract) and 
group seven (Normal rats + 5000 mg/kg of 
extract). Both control and test groups had six (6) 
rats per group.  
 
Test animals were administered doses of 
medicinal plant extract ranging from 200 mg/kg 
body weight to 5000 mg/kg. Control rats were 
given distilled water. Animals in all the groups 
were fasted overnight and observed for 10-20 
min before the administration of extract. Uvaria 
chamae extract was administered using an oral 
gastric gavage once a day (between 8.00 a.m. – 
9.00 a.m.) for 28 days. The animals were 
observed for signs of toxicity and mortality daily 
throughout the experimental period. The animals 
administered ethanol root extract at 1000, 2000, 
3000 and 5000 mg/kg did not survive up to the 
28th day of study. However, daily oral 
administration of ethanolic Uvaria chamae root 
extract at 200 or 500 mg/kg body weight for 28 
days did not induce any obvious symptoms of 
toxicity and mortality. On the 28th day, animals in 
groups 1 – 3 were fasted overnight, euthanized 
by decapitation and blood collected in 
appropriate tubes for biochemical and 
haematological assessments. Organs (pancreas, 





Serum lactate dehydrogenase (LDH), total 
protein, albumin, alanine amino transferase 
(ALT), aspartate amino transferase (AST), 
amylase, blood urea nitrogen (BUN), electrolyte 
and creatinine were determined using Vitros 350 
System Chemistry Ortho-Clinical Diagnostics 
[New Jersey, USA.IHVN/LAB/1001924]. White 
blood cell count, lymphocyte, monocytes, 
granulocytes, red blood cell (RBC), packed cell 
volume (PCV), haemoglobin (Hgb), mean 
corpuscular volume (MCV), mean corpuscular 
haemoglobin (MCH), mean corpuscular 
haemoglobin concentration (MCHC), and 
platelets were determined using PCE-210 
Haematological Analyzer [Full Automatic Blood 
Cell Counter-Model PCE-210 N Erma Inc., 
Tokyo, Japan]. 
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The organs (pancreas, liver and kidney) were 
harvested and immediately submerged in 10 % 
buffered formalin for 72 hours. The tissues were 
subsequently processed, embedded in paraffin, 
sectioned (4 µm) and stained with haematoxylin 





The biochemical and haematological data were 
expressed as mean ± standard error of the mean 
(SEM). The difference between the groups was 
tested using ANOVA. Duncan’s multiple range 
test was used to test for significant difference 




Biochemical, haematological and 
histopathological profiles 
 
Total protein and albumin levels were not 
significantly (p > 0.05) altered in the groups 
treated with ethanolic extract when compared to 
control (Figure 1). There was a significant (p < 
0.05) decrease in serum LDH activity in the 
animals administered 200 mg ethanolic extract 
(Figure 2).  Serum AST activity was significantly 
(p < 0.05) increased in the rats administered 500 
mg of ethanolic extract when compared to the 
control group (Figure 2). The administration of 
ethanolic extract to the animals did not 
significantly (p > 0.05) alter serum amylase 
activity among the groups (Figure 3).  
 
 
Figure 1: Effect of oral administration of 200 and 500 
mg/kg body weight of ethanol extract of U. chamae on 
serum proteins in Sprague Dawley rats. Serum 
concentrations of total protein and albumin in the liver 
were expressed as mean ± SEM. Values were not 
significantly different among the groups (p > 0.05). 
 
 
Figure 2: Effect of oral administration of 200 and 500 
mg/kg body weight of ethanolic extract of medicinal 
plant on serum liver enzymes in Sprague Dawley rats. 
Serum concentrations of LDH, AST, ALT and ALP in 
the liver were expressed as mean ± SEM; *p < 0.05 is 
significant compared to control 
 
 
Figure 3: Effect of oral administration of 200 and 500 
mg/kg body weight of ethanolic extract of Uvaria 
chamae on serum amylase in Sprague Dawley rats; 
serum concentration of amylase was expressed as 
mean ± SEM. Values were not significantly different 
among the groups (p > 0.05) 
 
However, K+ and Cl- ions were significantly (p < 
0.05) increased by the administration of 200 or 
500 mg/kg of ethanolic extract compared to the 
control group (Figure 4).  Serum BUN level was 
significantly (p < 0.05) reduced by the 
administration of 200 or 500 mg/kg of ethanolic 
extract compared to control (Figure 5). There 
was a significant (p < 0.05) increase in the 
platelets of rats treated with 500 mg of the 
extract compared to control (Figure 6). The red 
cell indices were not significantly (p > 0.05) 
altered in the treatment groups versus the control 
group (Figure 7). There was a significant (p < 
0.05) decrease in MCHC levels when compared 
to control group at 200 mg of the extract 
administration (Figure 7). 
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Figure 4: Effect of oral administration of 200 and 500 
mg/kg body weight of ethanolic extract of U. chamae 
on serum electrolytes in Sprague Dawley rats. Serum 
concentrations of Na+, K+, Cl- and HCO3- were 
expressed as mean ± SEM;  *p < 0.05 is significant 
compared to control 
 
 
Figure 5: Effect of oral administration of 200 and 500 
mg/kg body weight of ethanolic extract of medicinal 
plant on serum BUN and creatinine in Sprague Dawley 
rats. Serum concentrations of BUN and creatinine 
were expressed as mean ± SEM.  * P < 0.05 is 
significant compared to control 
 
 
Figure 6: Effect of oral administration of 200 and 500 
mg/kg body weight of ethanolic extract of Uvaria 
chamae on white blood cells, platelets, total and 
differentials in Sprague Dawley rats. The 
concentrations of WBC, LY, MO, GR and platelets 
were expressed as mean ± SEM. * P < 0.05 is 




Figure 7: Effect of oral administration of 200 mg and 
500 mg/kg body weight of ethanolic extract of Uvaria 
chamae on red cell indices in Sprague Dawley rats. 
The concentrations of RBC, Hgb, PCV, MCV, MCH 
and MCHC were expressed as mean ± SEM.  * P < 
0.05 is significant compared to control. 
 
 
   
Figure 8: Photomicrographs of rat pancreas, liver and 
kidney sections stained with H&E after 28 days of 
treatment with ethanolic extract of U. chamae. Plates 
1 and 2 (200 and 500 mg respectively) of rat pancreas 
showed well-formed normal islets [A], and normal 
exocrine glands [B]. Plates 3 (200 mg) of rat liver 
showed mild vascular congestion [A], normal 
hepatocyte architecture [B], mild periportal infiltrates of 
lymphocytes [C], and Plate 4 (500 mg) of rat liver 
showed mild portal congestion [A] and periportal 
infiltrates of lymphocytes [B]. Plates 5 and 6 (200 mg 
and 500 mg respectively) of rat kidney showed mild 
interstitial vascular congestion [A] and mild infiltrates 
of lymphocytes [B]. Magnification x 400. 
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From this study the administration of ethanolic 
extract of Uvaria chamae did not produce any 
deleterious effects on the liver or kidney of rats, 
and the immunity status and pancreatic islets of 
the treated animals were enhanced. No deaths 
or clinical abnormalities were noted in the groups 
treated with lower doses (that is 200 and 500 
mg/kg body weight) of ethanolic extract.  
Mortality of the animals occurred with doses of 
1000 mg/kg body weight and above. This 
observation may be due to the high 
concentration of active ingredients present in the 
ethanolic extract of Uvaria chamae. 
 
Hepatic impairment may also affect serum 
protein concentration [13]. Elevated serum AST 
and ALT levels are commonly used as sensitive 
markers of possible tissue damage, particularly 
liver damage [14]. Acute or chronic injury of the 
liver causes the elevation of enzyme activities in 
the bloodstream [15,16]. The cellular enzymes 
ALT and AST are present in low concentrations 
in serum under normal conditions. Increased 
synthesis of the enzymes or leakage from 
damaged cells may elevate enzyme 
concentrations in serum [13,17]. The observed 
non-significant changes in ALT and AST 
activities, and total protein and albumin levels in 
the rats administered 200 mg/kg of Uvaria 
chamae may be an indication of the absence of 
deleterious effect on liver function. The observed 
significant (p < 0.05) increase in AST and a 
corresponding non-significant increase in ALT 
when compared to control at 500 mg of Uvaria 
chamae extract indicated that the enzyme 
activities in the blood of animals were dose 
dependent.  
 
Histopathological examination of the pancreas of 
rats treated with ethanolic extract, showed well-
formed islets and normal exocrine glands. The 
healing enhancing effect on the pancreatic cells 
may partly be responsible for the reported 
hypoglycemic properties of Uvaria chamae 
extract [9]. 
 
Creatinine is a good indicator of renal function, 
since any elevation in the serum level is 
associated with marked failure of nephron 
function [9]. The administration of low doses of 
the extract (≤ 500 mg) did not significantly alter 
the level of creatinine in the serum, however the 
observed significant reduction in the level of BUN 
in the treatment groups is not clear, it is possible 
that the active ingredients in the doses of extract 
tested are acting differently. Some drugs have 
been reported to decrease BUN levels [18]. The 
characteristic histopathological findings of kidney 
were mild interstitial vascular congestion, 
dilatation and mild infiltrates of lymphocytes in 
the kidney, which suggests that consumption of 
ethanolic extract of Uvaria chamae at the tested 
dose of ≤ 500 mg may not have significant 
adverse effects on renal function. 
 
Hematopoietic system has been reported to be 
one of the most sensitive targets for toxic 
substances [19]. Hematological indices can be 
used to assess the degree of the deleterious 
effect of a plant extract on blood function of an 
animal [20]. Moreover, significant changes in the 
hematological indices have been reported to 
have higher predictive value for human toxicity 
when data from animal investigations are 
extrapolated to human settings and situations 
[21].  
 
The observed significant increase in platelets at 
500 mg of extract may not be indicative of 
adverse hematological changes, but suggestive 
of the extract possessing hematopoietic 
potentials, since the observed alterations were 
not reflected in the biochemical and 
histopathological parameters evaluated. A 
decrease in MCHC may be a failure in blood 
osmoregulation or plasma osmolarity [22], 
however in this study the observed significant 
(p<0.05) decrease at 200 mg of extract was not 
evidenced in the other indices of red cells which 
are in keeping with features of anemic condition. 
 
Histopathological examination of the pancreas of 
rats treated with ethanolic extract, showed well-
formed islets and normal exocrine glands. The 
healing enhancing effect on the pancreatic cells 
may partly be responsible for the reported 
hypoglycemic properties of Uvaria chamae 
extract [9]. The stained liver sections showed that 
a low dose of Uvaria chamae root extract may 
have caused mild lymphocytic infiltrates in the 
portal region, and renal interstitium.  Hence, the 
consumption of the extract may boost the 





The result of this study has demonstrated that 
lower doses of 200-500 mg/kg body weight of 
extract did not produce any harmful effects in the 
treated Sprague Dawley rats. However, at higher 
doses of the medicinal plant over 50% deaths 
occurred in the treated animals. It may therefore 
not be advisable for the use of high doses of this 
medicinal plant for the treatment of diseases. Our 
data was in rats which could only provide an 
indirect assessment of the ethanolic root extract 
for human use. 
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